Allergan AGN

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Nominees for 2014 Allocation Fund Manager of the Year


      Tue, 13 Jan 2015

      allocation peers in 2014. The fund's equity and bond sleeves both performed well in 2014. Stock winners included Allergan AGN , which nearly doubled in value during the year, PG&E PCG, and UnitedHealth Group UNH. A modest overweighting to

    2. 2014's Biggest Stock Winners: Is There Any Gas Left in the Tank?


      Wed, 7 Jan 2015

      their forward-looking prospects. Allergan AGN 2014 Return: 91.56% | Morningstar ..... Stars | Economic Moat Rating: Wide Allergan shares nearly doubled in value ..... announced it would be acquiring Allergan at $219 per share, in a $66

    3. Nominees for 2014 Domestic-Stock Fund Manager of the Year


      Mon, 5 Jan 2015

      Materials AMAT and Iron Mountain IRM, fared well in 2014, but the fund's biggest winner was relatively recent purchase Allergan AGN . Ahlsten and Allen added the drug company in 2013 because they believed its price, which has lagged in recent years

    4. Our Take on the Fourth Quarter


      Thu, 1 Jan 2015

      the combination of oil-services firms Baker Hughes BHI and Halliburton HAL and health-care names Actavis ACT and Allergan AGN . Sector-by-Sector Performance All but two stock sectors gained in the fourth quarter . Utilities and real estate

    5. Health Care: A Strong Run, but Some Stocks Still Look Undervalued


      Wed, 31 Dec 2014

      bid for AstraZeneca AZN following the failed attempt earlier in the year. However, the white knight acquisition of Allergan AGN by Actavis ACT to fend off Valeant VRX looks likely to complete and showcases the importance of scale and cost-cutting

    6. Friday Five: Wide-Moat Outperformers From 2014

      Video Reports

      Fri, 26 Dec 2014

      health care. Wide-moat [TICKER: AGN ] Allergan and [TICKER:ACT] Actavis were ..... was M&A that was driving that. Allergan will be acquired by [TICKER ..... of a bidding war. That brought Allergan stock up, but it also brought

      Allergan found at 0:50

      lot of outperformers; there was a lot of M&A in health care. Wide-moat [TICKER: AGN ] Allergan and [TICKER:ACT] Actavis were among some of those top performers. Glaser: They were actually the two top performers of wide moats this year, and really it was M&A that was driving that. Allergan will be acquired by [TICKER:ACT] Actavis after a bit of a bidding war. That brought Allergan stock up, but it also brought [TICKER:ACT] Actavis up quite a bit. We think this runup in [TICKER:ACT] Actavis actually is well substantiated. We
    7. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers


      Tue, 16 Dec 2014

      Uncertainty Market Cap (USD Mil) % Stock Holdings Allergan AGN 2 Wide 208.47 1.13 Medium 61,318 5.3 Appd Mats ..... with a 17.6% weighting for the benchmark index). Allergan AGN "> AGN , which has been the subject of a takeover battle

    8. Facial Aesthetics Market To 2020


      Tue, 9 Dec 2014

      include Valeant’s offer to acquire Allergan , Merz’s acquisition of BioFarm Medical ..... technologies. The key players covered are Allergan , Q-Med, Mentor, Medicis and Merz ..... technologies. Key players covered include Allergan , Q-Med AB, Mentor Corporation, Medicis

    9. For David Krempa - VRX


      Mon, 1 Dec 2014

      Do you expect to prepare an analyst note anytime soon on Valeant’s prospects following the abortive Allergan deal?

    10. Let's Make a Deal: The Outlook for Merger Funds


      Tue, 25 Nov 2014

      The recent spate of merger activity on Wall Street (including last week's $66 billion acquisition of Allergan by Actavis ACT) has raised the profile of a niche segment of the alternative mutual fund universe, merger-arbitrage funds

    « Prev12345Next »
    Content Partners